[1]
|
国家卫生健康委高血压诊疗研究重点实验室学术委员会. 高血压患者中原发性醛固酮增多症检出、诊断和治疗的指导意见[J]. 中华高血压杂志, 2021, 29(6): 508-518.
|
[2]
|
中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版) [J]. 中华内分泌代谢杂志, 2020, 36(9): 727-736.
|
[3]
|
Xu, Z., Yang, J., Hu, J., Song, Y., He, W., Luo, T., Cheng, Q., Ma, L., Luo, R., Fuller, P.J., Cai, J., Li, Q. and Yang, S. (2020) Primary Aldosteronism in Patients in China with Recently Detected Hypertension. Journal of the American College of Cardiology, 75, 1913-1922. https://doi.org/10.1016/j.jacc.2020.02.052
|
[4]
|
Wang, L., Li, N., Yao, X., Chang, G., Zhang, D., Heizhati, M., Wang, M., Luo, Q. and Kong, J. (2017) Detection of Secondary Causes and Coexisting Diseases in Hy-pertensive Patients: OSA and PA Are the Common Causes Associated with Hypertension. BioMed Research Interna-tional, 2017, Article ID: 6490349.
https://doi.org/10.1155/2017/6490349
|
[5]
|
Mosso, L., Carvajal, C., González, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A. and Fardella, C.E. (2003) Primary Aldosteronism and Hypertensive Disease. Hypertension, 42, 161-165.
https://doi.org/10.1161/01.HYP.0000079505.25750.11
|
[6]
|
Calhoun, D.A. (2007) Is There an Unrecognized Epi-demic of Primary Aldosteronism? (Pro). Hypertension, 50, 447-453. https://doi.org/10.1161/HYPERTENSIONAHA.106.086116
|
[7]
|
Li, Y., Teng, D., Ba, J., Chen, B., Du, J., He, L., Lai, X., Teng, X., Shi, X., Li, Y., Chi, H., Liao, E., Liu, C., Liu, L., Qin, G., Qin, Y., Quan, H., Shi, B., Sun, H., Tang, X., Tong, N., Wang, G., Zhang, J.-A., Wang, Y., Xue, Y., Yan, L., Yang, J., Yang, L., Yao, Y., Ye, Z., Zhang, Q., Zhang, L., Zhu, J., Zhu, M., Ning, G., Mu, Y., Zhao, J., Shan, Z. and Teng, W. (2020) Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China. Thyroid, 30, 568-579. https://doi.org/10.1089/thy.2019.0067
|
[8]
|
Santori, C., Di Veroli, C., Di Lazzaro, F., Caliumi, C., Petramala, L., Cotesta, D., Iorio, M., Serra, V., Celi, M., D’Erasmo, E. and Letizia, C. (2005) High Preva-lence of Thyroid Disfunction in Primary Hyperaldosteronism. Recenti Progressi in Medicina, 96, 352-356.
|
[9]
|
Armanini, D., Nacamulli, D., Scaroni, C., Lumachi, F., Selice, R., Fiore, C., Favia, G. and Mantero, F. (2003) High Prevalence of Thyroid Ultrasonographic Abnormalities in Primary Aldosteronism. Endocrine, 22, 155-160.
https://doi.org/10.1385/ENDO:22:2:155
|
[10]
|
Turchi, F., Ronconi, V., di Tizio, V., Boscaro, M.G. and Giacchetti, G. (2011) Blood Pressure, Thyroid-Stimulating Hormone, and Thyroid Disease Prevalence in Primary Aldosteronism and Essential Hypertension. American Journal of Hypertension, 24, 1274-1279. https://doi.org/10.1038/ajh.2011.144
|
[11]
|
Joanna, M., Rоussanka, K., Atanaska, E., Emil, N., Vladimir, V. and Sabina, Z. (2019) Thyroid Аbnormalities in Primary Aldosteronism. ARC Journal of Diabetes and Endocrinology, 5, 1-7.
https://doi.org/10.20431/2455-5983.0501001
|
[12]
|
Molina-Garrido, M.J., Enríquez, R., Mora-Rufete, A., Sirvent, A.E. and Mora-Rufete, A. (2007) Primary Hyperaldosteronism Associated with Vitiligo Vulgaris and Autoimmune Hy-pothyroidism. The American Journal of the Medical Sciences, 333, 178-180. https://doi.org/10.1097/MAJ.0b013e3180319488
|
[13]
|
Krysiak, R. and Okopien, B. (2011) Coexistence of Primary Aldosteronism and Hashimoto’s Thyroiditis. Rheumatology International, 32, 2561-2563. https://doi.org/10.1007/s00296-011-2032-6
|
[14]
|
Gunatilake, S.S.C. and Bulugahapitiya, U. (2017) Coexistence of Primary Hyperaldosteronism and Graves’ Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coinci-dence—A Case Report and Review of the Literature. Case Reports in Endocrinology, 10, 405-458. https://doi.org/10.1155/2017/4050458
|
[15]
|
Sabbadin, C., Mian, C., Nacamulli, D., Donà, G., Presotto, F., Betterle, C.B., Bordin, M., Bordin, L. and Armanini, D. (2017) Association of Primary Aldosteronism with Chronic Thyroiditis. Endocrine, 55, 303-306.
https://doi.org/10.1007/s12020-016-0880-2
|
[16]
|
Lang, K., Weber, K., Quinkler, M., Dietz, A.S., Wallaschofski, H., Hannemann, A., Friedrichs, N., Rump, L.C., Heinze, B., Fuss, C.T., Quack, I., Willenberg, H.S., Reincke, M., Allolio, B. and Hahner, S. (2016) Prevalence of Malignancies in Patients with Primary Aldosteronism. The Journal of Clinical En-docrinology & Metabolism, 101, 1656-1663.
https://doi.org/10.1210/jc.2015-3405
|
[17]
|
Herrada, A.A., Contreras, F.J., Marini, N.P., Amador, C.A., González, P.A., Cortés, C.M., Riedel, C.A., Carvajal, C.A., Figueroa, F., Michea, L.F., Fardella, C.E. and Kalergis, A.M. (2010) Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity. The Journal of Immunology, 184, 191-202.
https://doi.org/10.4049/jimmunol.0802886
|
[18]
|
Herrada, A.A., Campino, C., Amador, C.A., Michea, L.F., Fardella, C.E. and Kalergis, A.M. (2011) Aldosterone as a Modulator of Immunity: Implications in the Organ Damage. Journal of Hypertension, 29, 1684-1692.
https://doi.org/10.1097/HJH.0b013e32834a4c75
|
[19]
|
Zake, T., Skuja, S., Kalere, I., Konrade, I. and Groma, V. (2019) Upregulated Tissue Expression of T Helper (Th) 17 Pathogenic Interleukin (IL)-23 and IL-1β in Hashimoto’s Thyroiditis but Not in Graves’ Disease. Endocrine Journal, 66, 423-430. https://doi.org/10.1507/endocrj.EJ18-0396
|
[20]
|
Eguchi, K., Iwakura, Y., Ichikawa, T., Saitoh, O., Kuriya, G., Na-gayama, Y., Abiru, N. and Horie, I. (2009) T Helper Type 17 Immune Response Plays an Indispensable Role for Devel-opment of Iodine-Induced Autoimmune Thyroiditis in Nonobese Diabetic-H2h4 Mice. Endocrinology, 150, 5135-5142. https://doi.org/10.1210/en.2009-0434
|
[21]
|
Stadhouders, R., Lubberts, E. and Hendriks, R.W. (2018) A Cellular and Molecular View of T Helper 17 Cell Plasticity in Autoimmunity. Journal of Autoimmunity, 87, 1-15. https://doi.org/10.1016/j.jaut.2017.12.007
|
[22]
|
Klatka, M., Grywalska, E., Partyka, M., Charytanowicz, M., Kiszczak-Bochynska, E. and Rolinski, J. (2014) Th17 and Treg Cells in Adolescents with Graves’ Disease. Impact of Treatment with Methimazole on These Cell Subsets. Autoimmunity, 47, 201-211. https://doi.org/10.3109/08916934.2013.879862
|
[23]
|
Manosroi, W., Atthakomol, P., Wattanawitawas, P. and Bu-ranapin, S. (2022) Differences in Glycemic Abnormalities between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology, 13, Article 870074. https://doi.org/10.3389/fendo.2022.870047
|
[24]
|
Chatterjee, R., Davenport, C.A., Svetkey, L.P., Batch, B.C., Lin, P.-H., Ramachandran, V.S., Fox, E.R., Harman, J., Yeh, H.-C., Selvin, E., Correa, A., Butler, K. and Edelman, D. (2017) Serum Potassium Is a Predictor of Incident Diabetes in African Americans with Normal Aldosterone: The Jackson Heart Study. The American Journal of Clinical Nutrition, 105, 442-449. https://doi.org/10.3945/ajcn.116.143255
|
[25]
|
龙入虹. 老年2型糖尿病合并甲状腺功能异常的危险因素[J]. 中国老年医学杂志, 2016, 36(13): 3191-3193.
|
[26]
|
Jali, M.V., Kambar, S., Jali, S.M., Pawar, N. and Nalawade, P. (2017) Prevalence of Thyroid Dys-function among Type 2 Diabetes Mellitus Patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11, S105-S108.
https://doi.org/10.1016/j.dsx.2016.12.017
|
[27]
|
Drechsler, C., Schneider, A., Gutjahr-Lengsfeld, L., Kroiss, M., Carrero, J.J., Krane, V., Allolio, B., Wanner, C. and Fassnacht, M. (2014) Thyroid Function, Cardiovascular Events, and Mortality in Diabetic Hemodialysis Patients. American Journal of Kidney Diseases, 63, 988-996. https://doi.org/10.1053/j.ajkd.2013.10.009
|
[28]
|
Lee, Y.-J., Kim, C.-H., Kwack, J.-Y., Ahn, J.-W., Kim, S.-H., Chae, H.-D. and Kang, B.-M. (2014) Subclinical Hypothyroidism Diagnosed by Thyrotropin-Releasing Hormone Stim-ulation Test in Infertile Women with Basal Thyroid-Stimulating Hormone Levels of 2.5 to 5.0 mIU/L. Obstetrics & Gy-necology Science, 57, 507-512.
https://doi.org/10.5468/ogs.2014.57.6.507
|
[29]
|
Sponziello, M.L., Bruno, R., Durante, C., D’Agostino, M., Cor-radino, R., Giannasio, P., Ciociola, E., Ferretti, E., Maranghi, M., Verrienti, A., De Toma, G., Filetti, S. and Russo, D. (2010) Growth Factor Receptors Gene Expression and Akt Phosphorylation in Benign Human Thyroid Nodules Are Unaffected by Chronic Thyrotropin Suppression. Hormone and Metabolic Research, 43, 22-25. https://doi.org/10.1055/s-0030-1265226
|
[30]
|
张桂玲, 刘娇, 谭博, 刘涛. 初诊2型糖尿病患者甲状腺激素和甲状腺自身抗体的变化[J]. 河北医药, 2015, 37(19): 2917-2919.
|
[31]
|
韩洁, 许婧, 曹宁, 毕长华, 孙茜, 张伟, 赵玉珍, 张朝, 云任康. 2型糖尿病合并甲状腺功能减退的影响因素分析研究[J]. 临床与病理杂志, 2016, 36(3): 264-269.
|
[32]
|
孙黎明, 马红萍, 夏晓露, 邬东江. 老年2型糖尿病合并甲状腺功能异常的研究进展[J]. 标记免疫分析与临床, 2023, 30(9): 1605-1610.
|
[33]
|
刘巍, 包塔娜, 刘宇佳, 许秉全, 许莉, 孙彦红. Graves病合并糖尿病应用放射性-碘131治疗152例分析[J]. 中国地方病防治杂, 2013, 28(2): 152-153.
|
[34]
|
Lambadiari, V., Mitrou, P., Maratou, E., Raptis, A.E., Tountas, N., Raptis, S.A. and Dimitriadis, G. (2010) Thyroid Hormones Are Positively Asso-ciated with Insulin Resistance Early in the Development of Type 2 Diabetes. Endocrine, 39, 28-32. https://doi.org/10.1007/s12020-010-9408-3
|
[35]
|
李晓玉, 陆守荣, 芦嘉琪, 李昕逸, 杨颖, 洪侃. 原发性醛固酮增多症与糖代谢紊乱的研究进展[J]. 中国临床保健杂志, 2023, 26(3): 419-424.
|
[36]
|
Min, S.H., Kim, S.-H., Jeong, I.-K., Cho, H.C., Jeong, J.-O., Lee, J.-H., Kang, H.-J., Kim, H.S., Park, K.S. and Lim, S. (2018) Independent Association of Serum Aldosterone Level with Metabolic Syndrome and Insulin Resistance in Korean Adults. Korean Circulation Journal, 48, 198-208. https://doi.org/10.4070/kcj.2017.0200
|
[37]
|
Morshed, S.A., Ma, R., Latif, R. and Davies, T.F. (2018) Biased Signaling by Thyroid Stimulating Hormone Receptor Specific Antibodies Determines Thy-rocyte Survival in Autoimmunity. Science Signaling, 11, 4120-4128.
https://doi.org/10.1126/scisignal.aah4120
|
[38]
|
Shi, Y., Wang, H., Su, Z., Chen, J., Xue, Y., Wang, S., Xue, Y., He, Z., Yang, H., Zhou, C., Kong, F., Liu, Y., Yang, P., Lu, L., Shao, Q., Huang, X. and Xu, H. (2010) Differentiation Im-balance of Th1/ Th17 in Peripheral Blood Mononuclear Cells Might Contribute to Pathogenesis of Hashimoto’s Thyroidi-tis. Scandinavian Journal of Immunology, 72, 250-255. https://doi.org/10.1111/j.1365-3083.2010.02425.x
|
[39]
|
Boi, F., Lai, M.L., Marziani, B., Minerba, L., Faa, G. and Mariotti, S. (2005) High Prevalence of Suspicious Cytology in Thyroid Nodules Associated with Positive Thyroid Autoantibodies. European Journal of Endocrinology, 153, 637-642. https://doi.org/10.1530/eje.1.02020
|
[40]
|
Spencer, C.A. (2011) Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC). The Journal of Clinical Endocrinology & Metab-olism, 96, 3615-3627.
https://doi.org/10.1210/jc.2011-1740
|
[41]
|
Paparodis, R., Imam, S., Todorova-Koteva, K., Staii, A. and Jaume, J.C. (2014) Hashimoto’s Thyroiditis Pathology and Risk for Thyroid Cancer. Thyroid, 24, 1107-1114. https://doi.org/10.1089/thy.2013.0588
|
[42]
|
李如茵, 李晓斌. 桥本甲状腺炎与甲状腺乳头状癌发生机制的研究进展[J]. 国际外科学杂志, 2021, 48(2): 128- 132.
|
[43]
|
张琳. 桥本甲状腺炎与甲状腺乳头状癌[J]. 家庭医学, 2023, 2023(19): 21.
|